Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Van Enckevort, Petra J.
TenVergert, Elisabeth M.
Kingma, Johannes
Koëter, Gerard H.
and
Rutten, Frans F. H.
1999.
Factors to Consider When Designing Phase III Clinical Trials Involving Economic Evaluations.
Perceptual and Motor Skills,
Vol. 89,
Issue. 3_suppl,
p.
1059.
van den Berg, Jan W.K.
van Enckevort, Petra J.
Ten Vergert, Elisabeth M.
Postma, Dirkje S.
van der Bij, Wim
and
Koe¨ter, Gerard H.
2000.
Bronchiolitis Obliterans Syndrome and Additional Costs of Lung Transplantation.
Chest,
Vol. 118,
Issue. 6,
p.
1648.
Sharples, Linda D
Taylor, Gordon J
Karnon, Jonathan
Caine, Noreen
Buxton, Martin
McNeil, Keith
and
Wallwork, John
2001.
A model for analyzing the cost of the main clinical events after lung transplantation.
The Journal of Heart and Lung Transplantation,
Vol. 20,
Issue. 4,
p.
474.
TENVERGER, E. M.
2001.
QUALITY OF LIFE BEFORE AND AFTER LUNG TRANSPLANTATION IN PATIENTS WITH EMPHYSEMA VERSUS OTHER INDICATIONS.
Psychological Reports,
Vol. 89,
Issue. 7,
p.
707.
TenVergert, E. M.
Vermeulen, K. M.
Geertsma, A.
van Enckevort, P. J.
de Boer, W. J.
van der Bij, W.
and
Koëter, G. H.
2001.
Quality of Life before and after Lung Transplantation in Patients with Emphysema versus other Indications.
Psychological Reports,
Vol. 89,
Issue. 3,
p.
707.
van Enckevort, Petra J.
Zwaveling, Jan H.
Bottema, Jan T.
Maring, John K.
Klompmaker, Ids J.
Slooff, Maarten J.H.
and
Ten Vergert, Elisabeth M.
2001.
Cost Effectiveness of Selective Decontamination of the Digestive Tract in Liver Transplant Patients.
PharmacoEconomics,
Vol. 19,
Issue. Parts 1 and 2,
p.
523.
Anyanwu, Ani C.
McGuire, Alistair
Rogers, Chris A.
and
Murday, A.J.
2002.
An economic evaluation of lung transplantation.
The Journal of Thoracic and Cardiovascular Surgery,
Vol. 123,
Issue. 3,
p.
411.
Ouwens, J.P
Groen, H
TenVergert, E.M
Koëter, G.H
de Boer, W.J
and
van der Bij, W
2002.
Simulated waiting list prioritization for equitable allocation of donor lungs.
The Journal of Heart and Lung Transplantation,
Vol. 21,
Issue. 7,
p.
797.
Egan, Thomas M.
2002.
QALYs or quackery? The quagmire of quantifying the cost of breathing.
The Journal of Thoracic and Cardiovascular Surgery,
Vol. 123,
Issue. 3,
p.
406.
Visser, K.
de Vries, S.O.
Kitslaar, P.J.E.H.M.
van Engelshoven, J.M.A.
and
Hunink, M.G.M.
2003.
Cost-effectiveness of diagnostic imaging work-up and treatment for patients with intermittent claudication in The Netherlands.
European Journal of Vascular and Endovascular Surgery,
Vol. 25,
Issue. 3,
p.
213.
Ouwens, J.P.
Groen, H.
van der Bij, W.
and
TenVergert, E.M.
2003.
An economic evaluation of lung transplantation.
The Journal of Thoracic and Cardiovascular Surgery,
Vol. 125,
Issue. 5,
p.
1175.
Kaló, Z
2003.
Economic aspects of renal transplantation.
Transplantation Proceedings,
Vol. 35,
Issue. 3,
p.
1223.
Ouwens, Jan Paul
Enckevort, Petra J.
TenVergert, Els M.
Bonsel, Gauke J.
Bij, Wim
Haagsma, Els B.
Rutten, Frans F.H.
Slooff, Maarten J.H.
and
Koeter, Gerard H.
2003.
The cost effectiveness of lung transplantation compared with that of heart and liver transplantation in the Netherlands.
Transplant International,
Vol. 16,
Issue. 2,
p.
123.
Koopmanschap, Marc A.
and
Rutten, Frans F.H.
2003.
The Drug Budget Silo Mentality: The Dutch Case.
Value in Health,
Vol. 6,
Issue. s1,
p.
S46.
Roels, Leo
Kalo, Zoltan
Boesebeck, Detlef
Whiting, James
and
Wight, Celia
2003.
Cost-benefit approach in evaluating investment into donor action: the German case.
Transplant International,
Vol. 16,
Issue. 5,
p.
321.
Choong, Cliff K
and
Meyers, Bryan F
2004.
Quality of life after lung transplantation.
Thoracic Surgery Clinics,
Vol. 14,
Issue. 3,
p.
385.
Richardson, Gerald
and
Manca, Andrea
2004.
Calculation of quality adjusted life years in the published literature: a review of methodology and transparency.
Health Economics,
Vol. 13,
Issue. 12,
p.
1203.
Groen, H.
Van Der Bij, W.
Koëter, G.H.
and
TenVergert, E.M.
2004.
Cost-Effectiveness of Lung Transplantation in Relation to Type of End-Stage Pulmonary Disease.
American Journal of Transplantation,
Vol. 4,
Issue. 7,
p.
1155.
Tengs, Tammy O.
2004.
Cost-Effectiveness versus Cost–Utility Analysis of Interventions for Cancer: Does Adjusting for Health-Related Quality of Life Really Matter?.
Value in Health,
Vol. 7,
Issue. 1,
p.
70.
Oostenbrink, J.B.
Rutten-van Mölken, M.P.M.H.
Al, M.J.
Van Noord, J.A.
and
Vincken, W.
2004.
One-year cost-effectiveness of tiotropiumversusipratropium to treat chronic obstructive pulmonary disease.
European Respiratory Journal,
Vol. 23,
Issue. 2,
p.
241.